{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:07:19Z","timestamp":1770894439915,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Jining city science and technology development plans"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s10549-015-3302-x","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T19:29:01Z","timestamp":1429644541000},"page":"119-126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer"],"prefix":"10.1007","volume":"150","author":[{"given":"De-di","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-ning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-zhen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,13]]},"reference":[{"issue":"7","key":"3302_CR1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1470-2045(13)70567-9","volume":"15","author":"L Fan","year":"2014","unstructured":"Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM, Goss PE (2014) Breast\u00a0cancer\u00a0in\u00a0China. Lancet Oncol 15(7):279\u2013289. doi: 10.1016\/S1470-2045(13)70567-9","journal-title":"Lancet Oncol"},{"issue":"1","key":"3302_CR2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/1430.15820","volume":"100","author":"HS Won","year":"2014","unstructured":"Won HS, Lee KE, Sung SH, Choi MY, Jo JY, Nam EM, Mun YC, Seong CM, Lee SN (2014) Topoisomerase II alpha and microtubule-associated protein- tau as a predictive marker in axillary lymph node positive breast cancer. Tumori 100(1):80\u201386. doi: 10.1700\/1430.15820","journal-title":"Tumori"},{"issue":"3","key":"3302_CR3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10549-014-3043-2","volume":"146","author":"E Munzone","year":"2014","unstructured":"Munzone E, Bagnardi V, Rotmensz N, Sporchia A, Mazza M, Pruneri G, Intra M, Sciandivasci A, Gentilini O, Luini A, Viale G, Veronesi P, Colleoni M (2014) Prognostic relevance of peritumoral vascular invasion in immunohistochemically defined subtypes of node-positive breast cancer. Breast Cancer Res Treat 146(3):573\u2013582. doi: 10.1007\/s10549-014-3043-2","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3302_CR4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00268-008-9782-7","volume":"33","author":"CH Yip","year":"2009","unstructured":"Yip CH, Taib NA, Tan GH, Ng KL, Yoong BK, Choo WY (2009) Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery? World J Surg 33(1):54\u201357. doi: 10.1007\/s00268-008-9782-7","journal-title":"World J Surg"},{"issue":"16","key":"3302_CR5","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1002\/cncr.26725","volume":"118","author":"M Sakakibara","year":"2012","unstructured":"Sakakibara M, Fujimori T, Miyoshi T, Nagashima T, Fujimoto H, Suzuki HT, Ohki Y, Fushimi K, Yokomizo J, Nakatani Y, Miyazaki M (2012) Aldehyde dehydrogenase 1-positive cells in axillary lymph node metastases after chemotherapy as a prognostic factor in patients with lymph node-positive breast cancer. Cancer 118(16):3899\u20133910. doi: 10.1002\/cncr.26725","journal-title":"Cancer"},{"issue":"1","key":"3302_CR6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jnci.2013.10.001","volume":"26","author":"TR Elkhodary","year":"2014","unstructured":"Elkhodary TR, Ebrahim MA, Hatata EE, Niazy NA (2014) Prognostic value of lymph node ratio in node-positive breast cancer in Egyptian patients. J Egypt Natl Canc Inst 26(1):31\u201335. doi: 10.1016\/j.jnci.2013.10.001","journal-title":"J Egypt Natl Canc Inst"},{"issue":"1","key":"3302_CR7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/bcr3065","volume":"14","author":"JL Andrews","year":"2012","unstructured":"Andrews JL, Kim AC, Hens JR (2012) The role and function of cadherins in the mammary gland. Breast Cancer Res 14(1):203. doi: 10.1186\/bcr3065","journal-title":"Breast Cancer Res"},{"issue":"8","key":"3302_CR8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1039\/b719215k","volume":"4","author":"MP Stemmler","year":"2008","unstructured":"Stemmler MP (2008) Cadherins in development and cancer. Mol BioSyst 4(8):835\u2013850. doi: 10.1039\/B719215K","journal-title":"Mol BioSyst"},{"key":"3302_CR9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/B978-0-12-394311-8.00014-5","volume":"116","author":"A Gheldof","year":"2013","unstructured":"Gheldof A, Berx G (2013) Cadherins and epithelial-to-mesenchymal transition. Prog Mol Biol Transl Sci 116:317\u2013336. doi: 10.1016\/B978-0-12-394311-8.00014-5","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"22","key":"3302_CR10","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1242\/jcs.133975","volume":"126","author":"E Guillaume","year":"2013","unstructured":"Guillaume E, Comunale F, Do Khoa N, Planchon D, Bodin S, Gauthier-Rouviere C (2013) Flotillin microdomains stabilize cadherins at cell\u2013cell junctions. J Cell Sci 126(22):5293\u20135304. doi: 10.1016\/B978-0-12-394311-8.00014-5","journal-title":"J Cell Sci"},{"issue":"5","key":"3302_CR11","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/0008-5472.CAN-07-2953","volume":"68","author":"LW Hebbard","year":"2008","unstructured":"Hebbard LW, Garlatti M, Young LJ, Cardiff RD, Oshima RG, Ranscht B (2008) T- cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. Cancer Res 68(5):1407\u20131416. doi: 10.1158\/0008-5472.CAN-07-2953","journal-title":"Cancer Res"},{"issue":"8","key":"3302_CR12","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.ejca.2012.12.026","volume":"49","author":"M Philippova","year":"2013","unstructured":"Philippova M, Pfaff D, Kyriakakis E, Buechner SA, Iezzi G, Spagnoli GC, Schoenenberger AW, Erne P, Resink TJ (2013) T- cadherin loss promotes experimental metastasis of squamous cell carcinoma. Eur J Cancer 49(8):2048\u20132058. doi: 10.1016\/j.ejca.2012.12.026","journal-title":"Eur J Cancer"},{"issue":"2","key":"3302_CR13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.febslet.2008.12.042","volume":"583","author":"Y Adachi","year":"2009","unstructured":"Adachi Y, Takeuchi T, Nagayama T, Ohtsuki Y, Furihata M (2009) Zeb1- mediated T- cadherin repression increases the invasive potential of gallbladder cancer. FEBS Lett 583(2):430\u2013436. doi: 10.1016\/j.febslet.2008.12.042","journal-title":"FEBS Lett"},{"issue":"4","key":"3302_CR14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/mc.10088","volume":"35","author":"T Takeuchi","year":"2002","unstructured":"Takeuchi T, Liang SB, Ohtsuki Y (2002) Downregulation of expression of a novel cadherin molecule, T- cadherin, in basal cell carcinoma of the skin. Mol Carcinog 35(4):173\u2013179. doi: 10.1002\/mc.10088","journal-title":"Mol Carcinog"},{"issue":"6","key":"3302_CR15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1365-2443.2007.01092.x","volume":"12","author":"Y Mukoyama","year":"2007","unstructured":"Mukoyama Y, Utani A, Matsui S, Zhou S, Miyachi Y, Matsuyoshi N (2007) T- cadherin enhances cell-matrix adhesiveness by regulating beta1 integrin trafficking in cutaneous squamous carcinoma cells. Genes Cells 12(6):787\u2013796. doi: 10.1111\/j.1365-2443.2007.01092.x","journal-title":"Genes Cells"},{"issue":"3","key":"3302_CR16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1755-148X.2009.00568.x","volume":"22","author":"S Kuphal","year":"2009","unstructured":"Kuphal S, Martyn AC, Pedley J, Crowther LM, Bonazzi VF, Parsons PG, Bosserhoff AK, Hayward NK, Boyle GM (2009) H- cadherin expression reduces invasion of malignant melanoma. Pigment Cell Melanoma Res 22(3):296\u2013306. doi: 10.1111\/j.1755-148X.2009.00568.x","journal-title":"Pigment Cell Melanoma Res"},{"issue":"12","key":"3302_CR17","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/labinvest.2012.140","volume":"92","author":"L Ellmann","year":"2012","unstructured":"Ellmann L, Joshi MB, Resink TJ, Bosserhoff AK, Kuphal S (2012) BRN2 is a transcriptional repressor of CDH13 (T- cadherin) in melanoma cells. Invest 92(12):1788\u20131800. doi: 10.1038\/labinvest.2012.140","journal-title":"Invest"},{"issue":"15","key":"3302_CR18","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1158\/1078-0432.CCR-04-2455","volume":"11","author":"PB Makarla","year":"2005","unstructured":"Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO (2005) Promoter hypermethylation profile of ovarian epithelial neoplasms. Clin Cancer Res 11(15):5365\u20135369. doi: 10.1158\/1078-0432.CCR-04-2455","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3302_CR19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/sj.bjc.6602095","volume":"91","author":"K Hibi","year":"2004","unstructured":"Hibi K, Kodera Y, Ito K, Akiyama S, Nakao A (2004) Methylation pattern of CDH13 gene in digestive tract cancers. Br J Cancer 91(6):1139\u20131142. doi: 10.1038\/sj.bjc.6602095","journal-title":"Br J Cancer"},{"issue":"116","key":"3302_CR20","first-page":"1294","volume":"59","author":"Y Tang","year":"2012","unstructured":"Tang Y, Dai Y, Huo J (2012) Decreased expression of T- cadherin is associated with gastric cancer prognosis. Hepatogastroenterology 59(116):1294\u20131298. doi: 10.5754\/hge12016","journal-title":"Hepatogastroenterology"},{"issue":"12","key":"3302_CR21","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/cncr.23113","volume":"11","author":"DS Kim","year":"2007","unstructured":"Kim DS, Kim MJ, Lee JY, Kim YZ, Kim EJ, Park JY (2007) Aberrant methylation of E-cadherin and H- cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features. Cancer 11(12):2785\u20132792. doi: 10.1002\/cncr.23113","journal-title":"Cancer"},{"issue":"1","key":"3302_CR22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2559.1999.0728c.x","volume":"35","author":"T Takeuchi","year":"1999","unstructured":"Takeuchi T, Misaki A, Chen BK, Ohtsuki Y (1999) H- cadherin expression in breast cancer. Histopathology 35(1):87\u201388","journal-title":"Histopathology"},{"issue":"11","key":"3302_CR23","first-page":"4556","volume":"61","author":"KO Toyooka","year":"2001","unstructured":"Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF (2001) Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res 61(11):4556\u20134560","journal-title":"Cancer Res"},{"issue":"9","key":"3302_CR24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/gcc.20787","volume":"49","author":"AV Andreeva","year":"2010","unstructured":"Andreeva AV, Kutuzov MA (2010) Cadherin 13 in cancer. Genes Chromosomes Cancer 49(9):775\u2013790. doi: 10.1002\/gcc.20787","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"3302_CR25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nsmb.1781","volume":"17","author":"C Ciatto","year":"2010","unstructured":"Ciatto C, Bahna F, Zampieri N, VanSteenhouse HC, Katsamba PS, Ahlsen G, Harrison OJ, Brasch J, Jin X, Posy S, Vendome J, Ranscht B, Jessell TM, Honig B, Shapiro L (2010) T- cadherin structures reveal a novel adhesive binding mechanism. Nat Struct Mol Biol 17(3):339\u2013347. doi: 10.1038\/nsmb.1781","journal-title":"Nat Struct Mol Biol"},{"issue":"7","key":"3302_CR26","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nm0796-776","volume":"2","author":"SW Lee","year":"1996","unstructured":"Lee SW (1996) H- cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med 2(7):776\u2013782","journal-title":"Nat Med"},{"issue":"12","key":"3302_CR27","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1111\/j.1349-7006.2009.01333.x","volume":"100","author":"A Celebiler Cavusoglu","year":"2009","unstructured":"Celebiler Cavusoglu A, Kilic Y, Saydam S, Canda T, Ba\u015fkan Z, Sevinc AI, Sakizli M (2009) Predicting invasive phenotype with CDH1, CDH13, CD44, and TIMP3 gene expression in primary breast cancer. Cancer Sci 100(12):2341\u20132345. doi: 10.1111\/j.1349-7006.2009.01333.x","journal-title":"Cancer Sci"},{"issue":"10","key":"3302_CR28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/1471-2407-10-378","volume":"20","author":"W Feng","year":"2010","unstructured":"Feng W, Orlandi R, Zhao N, Carcangiu ML, Tagliabue E, Xu J, Bast RC Jr, Yu Y (2010) Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers. BMC Cancer 20(10):378","journal-title":"BMC Cancer"},{"issue":"2","key":"3302_CR29","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10549-011-1709-6","volume":"130","author":"Y Wang","year":"2011","unstructured":"Wang Y, Yin Q, Yu Q, Zhang J, Liu Z, Wang S, Lv S, Niu Y (2011) A retrospective study of breast cancer subtypes:the risk of relapse and the relations with treatments. Breast Cancer Res Treat 130(2):489\u2013498. doi: 10.1007\/s10549-011-1709-6","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3302_CR30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/147323000503300212","volume":"33","author":"T Takahashi","year":"2005","unstructured":"Takahashi T, Saegusa S, Sumino H, Nakahashi T, Iwai K, Morimoto S, Nojima T, Kanda T (2005) Adiponectin,\u00a0T-\u00a0cadherin\u00a0and\u00a0tumour necrosis factor-alpha in damaged cardiomyocytes from\u00a0autopsy\u00a0specimens. J Int Med Res 33(2):236\u2013244","journal-title":"J Int Med Res"},{"issue":"2","key":"3302_CR31","first-page":"157","volume":"8","author":"M Wang","year":"2014","unstructured":"Wang M, Kong D, Zhou Y, Wang W (2014) Expression and predictive value of prognosis of T-cadherin in breast cancer. Chin J Oper Proc Gen Surg 8(2):157\u2013160","journal-title":"Chin J Oper Proc Gen Surg"},{"issue":"1","key":"3302_CR32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/1319-3767.105916","volume":"19","author":"BJ Qasim","year":"2013","unstructured":"Qasim BJ, Ali HH, Hussein AG (2013) Immunohistochemical expression of matrix metalloproteinase-7 in human colorectal adenomas using specified automated cellular image analysis system: a clinicopathological study. Saudi J Gastroenterol. 19(1):23\u201327","journal-title":"Saudi J Gastroenterol."},{"key":"3302_CR33","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.humpath.2011.08.007","volume":"43","author":"A Cimino-Mathews","year":"2012","unstructured":"Cimino-Mathews A, Hicks JL, Illei PB et al (2012) Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy. Hum Pathol 43:1003\u20131011","journal-title":"Hum Pathol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3302-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-015-3302-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3302-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T14:36:43Z","timestamp":1717857403000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-015-3302-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["3302"],"URL":"https:\/\/doi.org\/10.1007\/s10549-015-3302-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}